Integrating traditional clinical ophthalmology with Systemic Medicine principles and personalized medicine. The goal, alongside standard therapies, is to promote eye health and attempt to preserve visual function over time.
In longevity research (Geroscience), a distinction is made between registry age (Chronological Age) and estimated cellular senescence (Biological Age).
Patients of the same age can present very different physiological profiles. Our clinical approach, rooted in personalized medicine, aims to identify and modulate lifestyle and metabolic risk factors to help extend visual wellbeing (Visual Healthspan).
Hover over the different factors to see how exposure to harmful agents or the adoption of protective lifestyle habits may theoretically influence the acceleration or slowing of cellular aging (Biological Age). This is a simplified representation derived from experimental models for educational purposes. The “pro‑longevity” factors described represent hypotheses supported by preliminary data, but there is currently no definitive evidence quantifying their impact on ocular biological age in humans.
Applying the study of aging mechanisms (Hallmarks of Aging) to personalized ophthalmic support. The relationships described between nutrients, lifestyle factors and epigenetic or mitochondrial mechanisms are based on experimental and observational studies. At present, there is no definitive evidence that these interventions causally modify ocular biological age or the clinical course of specific diseases, and they should be regarded as complementary support to standard therapies, not as a substitute.
The retina is a highly oxygen-consuming tissue. With age, cellular metabolic efficiency can physiologically decline. Targeted nutrition aims to provide substrates that support photoreceptor mitochondrial function.
RPE cells constantly dispose of visual waste products. Proper nutrition and lifestyle can support physiological cellular clearance processes, helping to counteract lipofuscin accumulation.
Environmental and dietary factors influence our DNA expression. Through clinical nutrition and specific molecules, we aim to encourage the activation of protective and antioxidant pathways.
Scientific literature highlights correlations between intestinal dysbiosis and low-grade systemic inflammation (inflammaging). Rebalancing the microbiota may help reduce pro-inflammatory factors affecting the eye.
| Area | Physiological Process | Support Objective |
|---|---|---|
| Mitochondria | Energy metabolism (ATP) | Antioxidant support |
| Autophagy | Metabolite disposal | Cellular detoxification support |
| Epigenetics | Gene Expression | Promotion of protective lifestyles |
| Microbiota | Immunological axis regulation | Inflammaging containment |
Some bioactive compounds commonly recommended for vision support potentially act through epigenetic mechanisms:
| Ocular Condition | Potential Epigenetic Intervention | Evidence / Clinical Note |
|---|---|---|
| AMD | Diet rich in methyl donors and carotenoids | Possible reduction of pathological methylation of metabolic genes. |
| Glaucoma | HDAC inhibitor molecules | Reversal of age-related epigenetic marks is an experimental target for optic nerve support modulation. |
| Diabetic Retinopathy | Antioxidant bioactive nutrients | Assists in counteracting the epigenetic "metabolic memory" caused by chronic hyperglycemia. |
The approach involves a general patient assessment that does not replace, but complements, traditional ophthalmic diagnostics. Through systemic history-taking (Pathobiography), metabolic imbalances and stress factors that may contribute to visual decline are evaluated.
Once the patient's susceptibility profile (Phlogotype) is analyzed, a personalized medicine pathway is suggested, which may include nutritional guidance, targeted supplementation, chronobiology, and lifestyle optimization, always in strict compliance with medical guidelines.
Considering the eye within the context of general metabolic and vascular health.
Promoting healthy lifestyles to support visual longevity (Healthspan).
Complementing conventional therapies with a personalized medicine plan.
Although the correlation between nutrition, DNA methylation, and ocular pathologies is investigated by observational studies and preclinical models, large-scale randomized clinical trials validating a specific "epigenetic diet" as a primary treatment are still lacking. All nutritional and personalized medicine approaches described here represent general metabolic support and in no way replace conventional ophthalmological and pharmacological therapies.